A multicentric study with arteether in patients of uncomplicated falciparum malaria.
dc.contributor.author | Asthana, O P | en_US |
dc.contributor.author | Srivastava, J S | en_US |
dc.contributor.author | Kamboj, V P | en_US |
dc.contributor.author | Valecha, N | en_US |
dc.contributor.author | Sharma, V P | en_US |
dc.contributor.author | Gupta, S | en_US |
dc.contributor.author | Pande, T K | en_US |
dc.contributor.author | Vishwanathan, K A | en_US |
dc.contributor.author | Mahapatra, K M | en_US |
dc.contributor.author | Nayak, N C | en_US |
dc.contributor.author | Mahapatra, P K | en_US |
dc.contributor.author | Mahanta, J | en_US |
dc.contributor.author | Srivastava, V K | en_US |
dc.contributor.author | Vasdev, | en_US |
dc.contributor.author | Singh, N | en_US |
dc.contributor.author | Shukla, M M | en_US |
dc.contributor.author | Balsara, A B | en_US |
dc.contributor.author | Mishra, S K | en_US |
dc.contributor.author | Satpathy, S K | en_US |
dc.contributor.author | Mohanty, S | en_US |
dc.contributor.author | Dash, B | en_US |
dc.date.accessioned | 2001-07-28 | en_US |
dc.date.accessioned | 2009-05-31T01:06:16Z | |
dc.date.available | 2001-07-28 | en_US |
dc.date.available | 2009-05-31T01:06:16Z | |
dc.date.issued | 2001-07-28 | en_US |
dc.description.abstract | Two hundred and sixty seven patients of uncomplicated P. falciparum malaria completed study in a multicentric phase III clinical trial of Arteether. Arteether was given intramuscularly in a dose of 150 mg daily for three consecutive days. Each patient was followed upto 28 days of alpha, beta arteether therapy. The cure rate was 97% with fever clearance time between 1-7 days (24-168 hours) and parasite clearance time between 1-3 days (24-72 hours). Parasite reappearance rate was found to be 3% and reported at only three of the centres. Following the treatment no adverse effect was observed on haematological, biochemical and vital clinical parameters. | en_US |
dc.description.affiliation | Central Drug Research Institute, Lucknow, India. | en_US |
dc.identifier.citation | Asthana OP, Srivastava JS, Kamboj VP, Valecha N, Sharma VP, Gupta S, Pande TK, Vishwanathan KA, Mahapatra KM, Nayak NC, Mahapatra PK, Mahanta J, Srivastava VK, Vasdev , Singh N, Shukla MM, Balsara AB, Mishra SK, Satpathy SK, Mohanty S, Dash B. A multicentric study with arteether in patients of uncomplicated falciparum malaria. Journal of the Association of Physicians of India. 2001 Jul; 49(): 692-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/91883 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Antimalarials --therapeutic use | en_US |
dc.subject.mesh | Artemisinins | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Malaria, Falciparum --drug therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Sesquiterpenes --therapeutic use | en_US |
dc.title | A multicentric study with arteether in patients of uncomplicated falciparum malaria. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Clinical Trial, Phase III | en_US |
dc.type | Journal Article | en_US |
dc.type | Multicenter Study | en_US |
Files
License bundle
1 - 1 of 1